{
    "medicine_id": "7d6f7ba223a3a93a21192a35501c588a39b50daf",
    "platform_id": "DB06461",
    "metadata": {
        "name": "Lonafarnib 50 mg 1 Capsule",
        "composition": "50 mg 1 Squalamine",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in ovarian cancer lung cancer and macular degeneration",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Squalamine"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Squalamine"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Squalamine"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Squalamine"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Squalamine"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Squalamine is combined with Pamidronic acid"
                    },
                    {
                        "drugbank-id": "DB00399",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Squalamine is combined with Zoledronic acid"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Squalamine is combined with Alendronic acid"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Squalamine is combined with Ibandronate"
                    },
                    {
                        "drugbank-id": "DB00720",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Squalamine is combined with Clodronic acid"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Squalamine is combined with Risedronic acid"
                    },
                    {
                        "drugbank-id": "DB01077",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Squalamine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Squalamine is combined with Tiludronic acid"
                    },
                    {
                        "drugbank-id": "DB06255",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Squalamine is combined with Incadronic acid"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Squalamine"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Squalamine"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Squalamine is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Squalamine"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Squalamine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}